Bora CDMO Bora CDMO

X

Find Acecainida manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Acecainida
Also known as: N-acetylprocainamide, 32795-44-1, Napa, Acekainid, Acecainida, Acecainidum
Molecular Formula
C15H23N3O2
Molecular Weight
277.36  g/mol
InChI Key
KEECCEWTUVWFCV-UHFFFAOYSA-N
FDA UNII
910Q707V6F

A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
1 2D Structure

Acecainida

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-acetamido-N-[2-(diethylamino)ethyl]benzamide
2.1.2 InChI
InChI=1S/C15H23N3O2/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19)
2.1.3 InChI Key
KEECCEWTUVWFCV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C
2.2 Other Identifiers
2.2.1 UNII
910Q707V6F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Acecainide Hydrochloride

2. Acecainide Monohydrochloride

3. Acetylprocainamide

4. Hydrochloride, Acecainide

5. Monohydrochloride, Acecainide

6. N Acetylprocainamide

7. N-acetylprocainamide

2.3.2 Depositor-Supplied Synonyms

1. N-acetylprocainamide

2. 32795-44-1

3. Napa

4. Acekainid

5. Acecainida

6. Acecainidum

7. N-acetyloprokainamid

8. Acetylprocainamide

9. Acecainide [inn]

10. 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide

11. N-acetylprocaine Amide

12. 4-acetamido-n-[2-(diethylamino)ethyl]benzamide

13. Acecainide;napa

14. Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-

15. N-acetylnovocainamide

16. N-acetyl-procainamide

17. Chebi:60728

18. Acetylprocainamide, N-

19. N-[2-(diethylamino)ethyl]-4-acetamidobenzamide

20. Chembl1097

21. Mls000069490

22. 910q707v6f

23. Acetanilide, 4'-((2-(diethylamino)ethyl)carbamoyl)-

24. Smr000059070

25. Acekainid [polish]

26. Acecainidum [inn-latin]

27. Acecainida [inn-spanish]

28. N-acetyloprokainamid [polish]

29. 4-acetamido-n-(2-(diethylamino)ethyl)benzamide

30. Brn 2868559

31. Unii-910q707v6f

32. Procainamide-n-acetyl

33. N-acetyl Procainamide

34. Acecainide [mi]

35. Opera_id_1541

36. Spectrum3_001843

37. Lopac-a-5909

38. Epitope Id:140121

39. Acecainide [who-dd]

40. Lopac0_000009

41. Bspbio_003226

42. Mls001146871

43. Schembl156943

44. N-acetylprocainamide, >=99%

45. Dtxsid6048414

46. Kbio3_002726

47. Hms2232g18

48. Hms3372e09

49. Bcp26213

50. Hy-b1109

51. Zinc1999404

52. Bdbm50151860

53. Akos016614968

54. N-acetyl Procainamide(<30%)

55. Ccg-204105

56. Cs-4707

57. Sdccgsbi-0049998.p003

58. Ncgc00015072-01

59. Ncgc00015072-02

60. Ncgc00015072-03

61. Ncgc00015072-04

62. Ncgc00015072-05

63. Ncgc00015072-06

64. Ncgc00015072-07

65. Ncgc00015072-13

66. Ncgc00023226-03

67. Ncgc00023226-04

68. As-57414

69. Sbi-0049998.p002

70. Db-048268

71. N-acetylprocainamide 1.0 Mg/ml In Methanol

72. Ft-0639052

73. Ab00384286_20

74. 4-acetylamino-n-(2-diethylamino-ethyl)-benzamide

75. A905428

76. J-018880

77. Q4726688

78. 4-(acetylamino)-n-[2-(diethylamino)ethyl]benzamide #

79. Brd-k07753030-003-01-0

80. Brd-k07753030-003-11-9

81. Z26393212

82. N-(4-{[2-(diethylamino)ethyl]carbamoyl}phenyl)ethanimidic Acid

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 277.36 g/mol
Molecular Formula C15H23N3O2
XLogP30.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass277.17902698 g/mol
Monoisotopic Mass277.17902698 g/mol
Topological Polar Surface Area61.4 Ų
Heavy Atom Count20
Formal Charge0
Complexity308
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


4.2 Metabolism/Metabolites

Acecainide is a known human metabolite of Procainamide.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY